Insmed | INSM

Aktienkurs
108.09
Täglich Wechseln
3.62 3.47%
Monatlich
1.59%
Jährlich
8.64%
Q2 Prognose
93.83

EPS Referenz Zeit Aktuell Konsens Zuletzt
2026-05-07 FY2026Q1 AM -0.76 -0.99 -1.42
2026-02-19 FY2025Q4 AM -1.54 -1.28 -1.32
2025-10-30 FY2025Q3 AM -1.75 -1.34 -1.27
2025-08-07 FY2025Q2 AM -1.70 -1.36 -1.94
2025-05-08 FY2025Q1 AM -1.42 -1.20 -1.06



Preis Chg Tag Jahr Datum
BioMarin Pharmaceutical 58.97 1.62 2.82% 6.89% 2026-06-26
Cytokinetics 81.63 0.83 1.03% 146.17% 2026-06-26
DBV Technologies 16.38 0.36 2.25% 77.85% 2026-06-26
Gilead Sciences 126.29 2.45 1.98% 14.11% 2026-06-26
Heron Therapeutics 0.42 0.01 1.83% -80.49% 2026-06-26
Insmed 108.09 3.62 3.47% 8.64% 2026-06-26
Novartis 155.66 0.75 0.48% 29.38% 2026-06-26
Ultragenyx Pharmaceutical 30.35 1.10 3.76% -16.89% 2026-06-26
Regeneron Pharmaceuticals 631.36 11.22 1.81% 21.18% 2026-06-26
Sarepta Therapeutics 16.11 0.09 0.56% -6.50% 2026-06-26

Preis Tag Jahr Datum
USND 25467 108.31 0.43% 25.62% 2026-06-26
US2000 3010 2.13 0.07% 38.55% 2026-06-26